Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 11/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | CASP1 | P29466 | 2/20 | 0.61 |
| ▸ | CASP7 | P55210 | 2/20 | 0.61 |
| ▸ | ATM | Q13315 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | SRC | P12931 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.61 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | AGER | Q15109 | 2/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30275399 | 1.00 | AR (0.70) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL10086178 | 0.88 | AR (0.55) | ARALDH1A1HPGDCASP1CASP7 | |
| Coumarin SCHEMBL6849968 | 0.88 | AR (0.56) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL29551746 | 0.85 | AR (0.75) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL144250 | 0.85 | AR (0.75) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL24803039 | 0.85 | AR (0.67) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL31331897 | 0.85 | AR (0.62) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL10086176 | 0.81 | CYP1A2 (0.53) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL3626007 | 0.80 | ALDH1A1 (0.80) | ARALDH1A1HPGDCASP1CASP7 | |
| SCHEMBL31331847 | 0.80 | AR (0.59) | ARALDH1A1HPGDCASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 899 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201624-A1 | NON-INVASIVE ENERGY UPCONVERSION METHODS AND SYSTEMS FOR IN-SITU PHOTOBIOMODULATION | IMMUNOLIGHT, LLC (US) | 2023-06-29 | — | — | US | claimed |
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | claimed |
| US-10493296-B2 | Non-invasive energy upconversion methods and systems for in-situ photobiomodulation | IMMUNOLIGHT, LLC (US) | 2019-12-03 | — | — | US | claimed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| US-20170096545-A1 | SOLID STATE DYE LASER AND METHODS FOR PREPARING THE SAME | KING ABDULAZIZ CITY SCIENCE & TECHNOLOGY (KACST) (SA) | 2017-04-06 | — | — | US | claimed |
| US-20170000908-A1 | A MICELLAR PARTICLE | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2017-01-05 | — | — | US | claimed |
| US-9526913-B2 | Non-invasive energy upconversion methods and systems | DUKE UNIVERSITY (US) | 2016-12-27 | — | — | US | claimed |
| US-5829448-A | ANTITUMOR | PHOTOGEN, INC. (US) | 1998-11-03 | — | — | US | claimed |
| US-5807605-A | Lubricant soluble fluorescent agent and method for its use in a system for detection of lubricant coatings | BECTON DICKINSON AND COMPANY (US) | 1998-09-15 | — | — | US | claimed |
| WO-1998018398-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION AND DETECTION OF MOLECULAR DIAGNOSTIC AGENTS | PHOTOGEN, INC. (US) | 1998-05-07 | — | — | WO | claimed |
| WO-1998018399-A1 | METHOD FOR IMPROVED SELECTIVITY IN PHOTO-ACTIVATION OF MOLECULAR AGENTS | PHOTOGEN, INC. (US) | 1998-05-07 | — | — | WO | claimed |
| US-5667840-A | Lubricant soluble fluorescent agent and method for its use in a system for detection of lubricant coatings | BECTON DICKINSON AND COMPANY | 1997-09-16 | — | — | US | claimed |
| EP-0793089-A2 | Lubricant-soluble fluorescent agent and method for its use in a system for detecting lubricant coatings | Becton, Dickinson and Company (US) | 1997-09-03 | — | — | EP | claimed |
| US-5610932-A | Solid state dye laser host | PHYSICAL SCIENCES, INC. (US) | 1997-03-11 | — | — | US | claimed |
| EP-0431452-B1 | Method for the optical distinction of dental materials and material used in this method | IVOCLAR AG (LI) | 1994-10-05 | — | — | EP | claimed |
| US-5102461-A | PROCESS FOR THE OPTICAL DISTINCTION OF A DENTAL MATERIAL AND DENTAL MATERIAL FOR SAID PROCESS | IVOCLAR AG (DE) | 1992-04-07 | — | — | US | claimed |
| EP-0431452-A2 | Method for the optical distinction of dental materials and material used in this method | IVOCLAR AG (LI) | 1991-06-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10493296-B2 | Non-invasive energy upconversion methods and systems for in-situ photobiomodulation | MAVS, NLN, FURIN | AR 4694/4885ALDH1A1 3589/4885HPGD 3470/4885 |
| US-20170000908-A1 | A MICELLAR PARTICLE | CHMP4B, NPC1L1, CAPG | AR 1571/4885ALDH1A1 2143/4885HPGD 4520/4885 |
| US-20230201624-A1 | NON-INVASIVE ENERGY UPCONVERSION METHODS AND SYSTEMS FOR IN-SITU PHOTOBIOMODULATION | MAVS, NLN, FURIN | AR 4694/4885ALDH1A1 3589/4885HPGD 3470/4885 |
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | AR 2694/4885ALDH1A1 262/4885HPGD 237/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | AR 2416/4885ALDH1A1 179/4885HPGD 704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.